[1]
2025. A Bidirectional Two-Sample Cis-Mendelian Randomization in the MHC Region of Immune Responses against Epstein-Barr Virus Nuclear Antigen 1 and Multiple Sclerosis. Epidemiology, Biostatistics, and Public Health. (Sep. 2025). DOI:https://doi.org/10.54103/2282-0930/29465.